Combo immunotherapy may herald new standard of care for kidney cancer – Medical Xpress
Combo immunotherapy may herald new standard of care for kidney cancerMedical XpressCombination immunotherapy with nivolumab and ipilimumab as tested in the kidney cancer study described here is already FDA-approved for treatment of melanoma, and is bei… Continue reading
